Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

doi:10.1084/jem.175.3.779

This Article

	Full Text (PDF, 1110K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Robertson, M. J.
	Articles by Ritz, J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Robertson, M. J.
	Articles by Ritz, J.


Social Bookmarking

	What's this?

ARTICLES

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

MJ Robertson, RJ Soiffer, SF Wolf, TJ Manley, C Donahue, D Young, SH Herrmann and J Ritz
Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.

Natural killer cell stimulatory factor (NKSF) is a 70-kD heterodimeric cytokine that was initially isolated from conditioned medium of human B lymphoblastoid cell lines. The effects of recombinant NKSF on the function of human peripheral blood NK cells were examined. NKSF directly augmented the cytolytic activity of freshly isolated NK cells. Both CD56dim and CD56bright NK cells demonstrated enhanced cytotoxicity after brief exposure to NKSF. In contrast, highly purified T lymphocytes did not exhibit major histocompatibility complex- unrestricted cytotoxicity after short-term culture with NKSF. Like interleukin 2 (IL-2), NKSF augmented the lysis of NK-sensitive, NK- resistant, and antibody-coated targets. Both NKSF and IL-2 induced marked upregulation of several NK cell adhesion molecules known to participate in cytolysis, including CD2, CD11a, and CD54. However, NKSF activates NK cells through a pathway distinct from that of IL-2, since the presence of anti-IL-2 receptor (anti-IL-2R) antibodies or IL-4 did not inhibit the effects of NKSF. NKSF by itself induced very little proliferation of resting NK cells. NK cells preactivated in vitro with IL-2 demonstrated enhanced proliferation to NKSF, but the degree of proliferation was always inferior to that induced by IL-2 alone. Moreover, NKSF strongly inhibited IL-2-induced proliferation of either resting or preactivated NK cells. This inhibition was not the result of decreased IL-2R expression, because NKSF-activated NK cells expressed higher levels of both IL-2Rs p75 and p55. Furthermore, NKSF did not inhibit the proliferation of mitogen-activated T cells, indicating a selective effect on NK cell proliferation. Human NK cells expanded in vivo by prolonged continuous infusions of IL-2 remained fully responsive to NKSF. Picomolar concentrations of NKSF were as effective as nanomolar concentrations of IL-2 in augmenting the cytolytic activity of NK cells expanded in vivo by IL-2. NKSF may play an important role in the regulation of human NK cell function, and its possible use as a therapeutic cytokine deserves further investigation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Silva, A., Andrews, D. M., Brooks, A. G., Smyth, M. J., Hayakawa, Y. (2008). Application of CD27 as a marker for distinguishing human NK cell subsets. Int Immunol 20: 625-630 [Abstract] [Full Text]
Little, R. F., Pluda, J. M., Wyvill, K. M., Rodriguez-Chavez, I. R., Tosato, G., Catanzaro, A. T., Steinberg, S. M., Yarchoan, R. (2006). Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood 107: 4650-4657 [Abstract] [Full Text]
Iinuma, H., Okinaga, K., Fukushima, R., Inaba, T., Iwasaki, K., Okinaga, A., Takahashi, I., Kaneko, M. (2006). Superior Protective and Therapeutic Effects of IL-12 and IL-18 Gene-Transduced Dendritic Neuroblastoma Fusion Cells on Liver Metastasis of Murine Neuroblastoma. J. Immunol. 176: 3461-3469 [Abstract] [Full Text]
Hofer, M., Hausmann, J., Staeheli, P., Pagenstecher, A. (2004). Cerebral Expression of Interleukin-12 Induces Neurological Disease via Differential Pathways and Recruits Antigen-Specific T Cells in Virus-Infected Mice. Am. J. Pathol. 165: 949-958 [Abstract] [Full Text]
Perez, O. D., Mitchell, D., Jager, G. C., Nolan, G. P. (2004). LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56+CD8+ natural killer cells. Blood 104: 1083-1093 [Abstract] [Full Text]
Pelloso, D., Cyran, K., Timmons, L., Williams, B. T., Robertson, M. J. (2004). Immunological Consequences of Interleukin 12 Administration after Autologous Stem Cell Transplantation. Clin. Cancer Res. 10: 1935-1942 [Abstract] [Full Text]
Tatsumi, T., Huang, J., Gooding, W. E., Gambotto, A., Robbins, P. D., Vujanovic, N. L., Alber, S. M., Watkins, S. C., Okada, H., Storkus, W. J. (2003). Intratumoral Delivery of Dendritic Cells Engineered to Secrete Both Interleukin (IL)-12 and IL-18 Effectively Treats Local and Distant Disease in Association with Broadly Reactive Tc1-type Immunity. Cancer Res. 63: 6378-6386 [Abstract] [Full Text]
Barao, I., Hudig, D., Ascensao, J. L. (2003). IL-15-Mediated Induction of LFA-1 Is a Late Step Required for Cytotoxic Differentiation of Human NK Cells from CD34+Lin- Bone Marrow Cells. J. Immunol. 171: 683-690 [Abstract] [Full Text]
Gollob, J. A., Veenstra, K. G., Parker, R. A., Mier, J. W., McDermott, D. F., Clancy, D., Tutin, L., Koon, H., Atkins, M. B. (2003). Phase I Trial of Concurrent Twice-Weekly Recombinant Human Interleukin-12 Plus Low-Dose IL-2 in Patients With Melanoma or Renal Cell Carcinoma. JCO 21: 2564-2573 [Abstract] [Full Text]
Eyles, J. L., Metcalf, D., Grusby, M. J., Hilton, D. J., Starr, R. (2002). Negative Regulation of Interleukin-12 Signaling by Suppressor of Cytokine Signaling-1. J. Biol. Chem. 277: 43735-43740 [Abstract] [Full Text]
Robertson, M. J., Pelloso, D., Abonour, R., Hromas, R. A., Nelson, R. P. Jr., Wood, L., Cornetta, K. (2002). Interleukin 12 Immunotherapy after Autologous Stem Cell Transplantation for Hematological Malignancies. Clin. Cancer Res. 8: 3383-3393 [Abstract] [Full Text]
Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A., Caligiuri, M. A. (2002). Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 100: 1935-1947 [Abstract] [Full Text]
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., Munz, C. (2002). Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells. JEM 195: 343-351 [Abstract] [Full Text]
Robertson, M. J. (2002). Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71: 173-183 [Abstract] [Full Text]
Tatsumi, T., Takehara, T., Kanto, T., Miyagi, T., Kuzushita, N., Sugimoto, Y., Jinushi, M., Kasahara, A., Sasaki, Y., Hori, M., Hayashi, N. (2001). Administration of Interleukin-12 Enhances the Therapeutic Efficacy of Dendritic Cell-based Tumor Vaccines in Mouse Hepatocellular Carcinoma. Cancer Res. 61: 7563-7567 [Abstract] [Full Text]
Tsurita, M., Kurokawa, M., Imakita, M., Fukuda, Y., Watanabe, Y., Shiraki, K. (2001). Early Augmentation of Interleukin (IL)-12 Level in the Airway of Mice Administered Orally with Clarithromycin or Intranasally with IL-12 Results in Alleviation of Influenza Infection. J. Pharmacol. Exp. Ther. 298: 362-368 [Abstract] [Full Text]
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., Caligiuri, M. A. (2001). Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 97: 3146-3151 [Abstract] [Full Text]
Brieland, J. K., Jackson, C., Menzel, F., Loebenberg, D., Cacciapuoti, A., Halpern, J., Hurst, S., Muchamuel, T., Debets, R., Kastelein, R., Churakova, T., Abrams, J., Hare, R., O'Garra, A. (2001). Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus. Infect. Immun. 69: 1554-1560 [Abstract] [Full Text]
Chakir, H., Camilucci, A. A., Filion, L. G., Webb, J. R. (2000). Differentiation of Murine NK Cells into Distinct Subsets Based on Variable Expression of the IL-12R{beta}2 Subunit. J. Immunol. 165: 4985-4993 [Abstract] [Full Text]
Sin, J.-I., Kim, J., Patchuk, C., Weiner, D. B. (2000). Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo. CVI 7: 751-758 [Abstract] [Full Text]
Ohno, R., Yamaguchi, Y., Toge, T., Kinouchi, T., Kotake, T., Shibata, M., Kiyohara, Y., Ikeda, S., Fukui, I., Gohchi, A., Sugiyama, Y., Saji, S., Hazama, S., Oka, M., Ohnishi, K., Ohhashi, Y., Tsukagoshi, S., Taguchi, T. (2000). A Dose-Escalation and Pharmacokinetic Study of Subcutaneously Administered Recombinant Human Interleukin 12 and Its Biological Effects in Japanese Patients with Advanced Malignancies. Clin. Cancer Res. 6: 2661-2669 [Abstract] [Full Text]
Martinet, O., Ermekova, V., Qiao, J. Q., Sauter, B., Mandeli, J., Chen, L., Chen, S.-H. (2000). Immunomodulatory Gene Therapy With Interleukin 12 and 4-1BB Ligand: Long- Term Remission of Liver Metastases in a Mouse Model. JNCI J Natl Cancer Inst 92: 931-936 [Abstract] [Full Text]
Wang, K. S., Frank, D. A., Ritz, J. (2000). Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 95: 3183-3190 [Abstract] [Full Text]
Gollob, J. A., Mier, J. W., Veenstra, K., McDermott, D. F., Clancy, D., Clancy, M., Atkins, M. B. (2000). Phase I Trial of Twice-Weekly Intravenous Interleukin 12 in Patients with Metastatic Renal Cell Cancer or Malignant Melanoma: Ability to Maintain IFN-{{gamma}} Induction Is Associated with Clinical Response. Clin. Cancer Res. 6: 1678-1692 [Abstract] [Full Text]
de Arruda Hinds, L. B., Previato, L. M., Previato, J. O., Vos, Q., Mond, J. J., Pecanha, L. M. T. (1999). Modulation of B-Lymphocyte and NK Cell Activities by Glycoinositolphospholipid Purified from Trypanosoma cruzi. Infect. Immun. 67: 6177-6180 [Abstract] [Full Text]
Bukowski, R. M., Rayman, P., Molto, L., Tannenbaum, C. S., Olencki, T., Peereboom, D., Tubbs, R., McLain, D., Budd, G. T., Griffin, T., Novick, A., Hamilton, T. A., Finke, J. (1999). Interferon-{{gamma}} and CXC Chemokine Induction by Interleukin 12 in Renal Cell Carcinoma. Clin. Cancer Res. 5: 2780-2789 [Abstract] [Full Text]
Chung, K F, Barnes, P J (1999). Cytokines in asthma. Thorax 54: 825-857 [Full Text]
Matsushita, T., Ando, K., Kimura, K., Ohnishi, H., Imawari, M., Muto, Y., Moriwaki, H. (1999). IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. Int Immunol 11: 657-665 [Abstract] [Full Text]
Smith, R. E., Donachie, A. M., Grdic, D., Lycke, N., Mowat, A. McI. (1999). Immune-Stimulating Complexes Induce an IL-12-Dependent Cascade of Innate Immune Responses. J. Immunol. 162: 5536-5546 [Abstract] [Full Text]
Gollob, J. A., Schnipper, C. P., Murphy, E. A., Ritz, J., Frank, D. A. (1999). The Functional Synergy Between IL-12 and IL-2 Involves p38 Mitogen-Activated Protein Kinase and Is Associated with the Augmentation of STAT Serine Phosphorylation. J. Immunol. 162: 4472-4481 [Abstract] [Full Text]
Sin, J.-I., Kim, J. J., Arnold, R. L., Shroff, K. E., McCallus, D., Pachuk, C., McElhiney, S. P., Wolf, M. W., Pompa-de Bruin, S. J., Higgins, T. J., Ciccarelli, R. B., Weiner, D. B. (1999). IL-12 Gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-Type CD4+ T Cell-Mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge. J. Immunol. 162: 2912-2921 [Abstract] [Full Text]
Pardoux, C., Ma, X., Gobert, S., Pellegrini, S., Mayeux, P., Gay, F., Trinchieri, G., Chouaib, S. (1999). Downregulation of Interleukin-12 (IL-12) Responsiveness in Human T Cells by Transforming Growth Factor-beta : Relationship With IL-12 Signaling. Blood 93: 1448-1455 [Abstract] [Full Text]
Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., Tosato, G. (1999). Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12. Blood 93: 1612-1621 [Abstract] [Full Text]
Sin, J.-I., Kim, J. J., Boyer, J. D., Ciccarelli, R. B., Higgins, T. J., Weiner, D. B. (1999). In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2�Mouse Model. J. Virol. 73: 501-509 [Abstract] [Full Text]
Robertson, M. J., Cameron, C., Atkins, M. B., Gordon, M. S., Lotze, M. T., Sherman, M. L., Ritz, J. (1999). Immunological Effects of Interleukin 12 Administered by Bolus Intravenous Injection to Patients with Cancer. Clin. Cancer Res. 5: 9-16 [Abstract] [Full Text]
Marinaro, M., Boyaka, P. N., Jackson, R. J., Finkelman, F. D., Kiyono, H., Jirillo, E., McGhee, J. R. (1999). Use of Intranasal IL-12 to Target Predominantly Th1 Responses to Nasal and Th2 Responses to Oral Vaccines Given with Cholera Toxin. J. Immunol. 162: 114-121 [Abstract] [Full Text]
Barnes, P. J., Chung, K. F., Page, C. P. (1998). Inflammatory Mediators of Asthma: An Update. Pharmacol. Rev. 50: 515-596 [Abstract] [Full Text]
Ahn, H.-J., Tomura, M., Yu, W.-G., Iwasaki, M., Park, W.-R., Hamaoka, T., Fujiwara, H. (1998). Requirement for Distinct Janus Kinases and STAT Proteins in T Cell Proliferation Versus IFN-{gamma} Production Following IL-12 Stimulation. J. Immunol. 161: 5893-5900 [Abstract] [Full Text]
Fogler, W. E., Volker, K., Watanabe, M., Wigginton, J. M., Roessler, P., Brunda, M. J., Ortaldo, J. R., Wiltrout, R. H. (1998). Recruitment of Hepatic NK Cells by IL-12 Is Dependent on IFN-{gamma} and VCAM-1 and Is Rapidly Down-Regulated by a Mechanism Involving T Cells and Expression of Fas. J. Immunol. 161: 6014-6021 [Abstract] [Full Text]
Anumanthan, A., Bensussan, A., Boumsell, L., Christ, A. D., Blumberg, R. S., Voss, S. D., Patel, A. T., Robertson, M. J., Nadler, L. M., Freeman, G. J. (1998). Cloning of BY55, a Novel Ig Superfamily Member Expressed on NK Cells, CTL, and Intestinal Intraepithelial Lymphocytes. J. Immunol. 161: 2780-2790 [Abstract] [Full Text]
Shaw, S. G., Maung, A. A., Steptoe, R. J., Thomson, A. W., Vujanovic3, N. L. (1998). Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with Flt3-Ligand: Implications for Anti-Cancer and Anti-Viral Therapy. J. Immunol. 161: 2817-2824 [Abstract] [Full Text]
Salvucci, O., Kolb, J. P., Dugas, B., Dugas, N., Chouaib, S. (1998). The Induction of Nitric Oxide by Interleukin-12 and Tumor Necrosis Factor-alpha in Human Natural Killer Cells: Relationship With the Regulation of Lytic Activity. Blood 92: 2093-2102 [Abstract] [Full Text]
Monteiro, J. M., Harvey, C., Trinchieri, G. (1998). Role of Interleukin-12 in Primary Influenza Virus Infection. J. Virol. 72: 4825-4831 [Abstract] [Full Text]
Siders, W. M., Wright, P. W., Hixon, J. A., Alvord, W. G., Back, T. C., Wiltrout, R. H., Fenton, R. G. (1998). T Cell- and NK Cell-Independent Inhibition of Hepatic Metastases by Systemic Administration of an IL-12-Expressing Recombinant Adenovirus. J. Immunol. 160: 5465-5474 [Abstract] [Full Text]
Voss, S. D., Daley, J., Ritz, J., Robertson, M. J. (1998). Participation of the CD94 Receptor Complex in Costimulation of Human Natural Killer Cells. J. Immunol. 160: 1618-1626 [Abstract] [Full Text]
Gollob, J. A., Murphy, E. A., Mahajan, S., Schnipper, C. P., Ritz, J., Frank, D. A. (1998). Altered Interleukin-12 Responsiveness in Th1 and Th2 Cells Is Associated With the Differential Activation of STAT5 and STAT1. Blood 91: 1341-1354 [Abstract] [Full Text]
Brieland, J. K., Remick, D. G., LeGendre, M. L., Engleberg, N. C., Fantone, J. C. (1998). In Vivo Regulation of Replicative Legionella pneumophila Lung Infection by Endogenous Interleukin-12. Infect. Immun. 66: 65-69 [Abstract] [Full Text]
Geldhof, A. B., Moser, M., Lespagnard, L., Thielemans, K., De Baetselier, P. (1998). Interleukin-12-Activated Natural Killer Cells Recognize B7 Costimulatory Molecules on Tumor Cells and Autologous Dendritic Cells. Blood 91: 196-206 [Abstract] [Full Text]
Sablotzki, A, Dehne, M, Welters, I, Menges, T, Lehmann, N, Gorlach, G, Osmer, C, Hempelmann, G (1997). Alterations of the cytokine network in patients undergoing cardiopulmonary bypass. Perfusion 12: 393-403 [Abstract]
Westergren, V., Viale, G., Dell'Orto, P., Pellegrini, C., Hellquist, H. B. (1997). RANTES Is More Prevalent in Bacterial Than in Nonbacterial Maxillary Sinusitis: And P-Selectin Is Preferentially Up-regulated in Diseased Mucosae. Arch Otolaryngol Head Neck Surg 123: 1103-1110 [Abstract]
Marinaro, M., Boyaka, P. N., Finkelman, F. D., Kiyono, H., Jackson, R. J., Jirillo, E., McGhee, J. R. (1997). Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type Responses to an Oral Vaccine Without Altering Mucosal IgA Responses. JEM 185: 415-428 [Abstract] [Full Text]
Ross, M. E., Caligiuri, M. A. (1997). Cytokine-Induced Apoptosis of Human Natural Killer Cells Identifies a Novel Mechanism to Regulate the Innate Immune Response. Blood 89: 910-918 [Abstract] [Full Text]
Rashleigh, S. P., Kusher, D. I., Endicott, J. N., Rossi, A. R., Djeu, J. Y. (1996). Interleukins 2 and 12 Activate Natural Killer Cytolytic Responses of Peripheral Blood Mononuclear Cells From Patients With Head and Neck Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg 122: 541-547 [Abstract]
Robertson, M. J., Ritz, J. (1996). Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment. The Oncologist 1: 88-97 [Abstract] [Full Text]
Barton, D. P. J., Blanchard, D. K., Duan, C., Roberts, W. S., Cavanagh, D., DeCesare, S., Djeu, J. Y. (1995). Interleukin-12 Synergizes With Interleukin-2 to Generate Lymphokine-Activated Killer Activity in Peripheral Blood Mononuclear Cells Cultured in Ovarian Cancer Ascitic Fluid. Reproductive Sciences 2: 762-771 [Abstract]